Learn

Changes to Medicare funding to allow a wider application of genetic testing for specific genetic conditions has created a larger audience of women and families turning to GPs to evaluate risk for genetic disorders. This can be a challenging area for many GPs to navigate and potentially counsel patients on outcomes.

Join A/Prof Indika Alahakoon, and Reproductive Specialist, as she shares why and when to test for families, and the complex conditions identified using these new technologies.

Details

Learning Objectives:

1. Review genetic conditions identified during the screening processes
2. Review current Medicare-approved and RACGP/RANZCOG testing guidelines
3. Discuss the impact of these tests related to patients undergoing fertility treatments.

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 4 weeks to be reflected on your CPD Home Dashboard.